EMCDDA Home
  • EN

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates5.340.631.412.84.72.81.41.022.12711194
Cocaine6.833.525.619.29.42.62.30.823.226661
Stimulants15.855.818.75.62.60.80.60.219.1107953
Hypnotics and sedatives7.419.913.58.913.17.86.722.732.5282141
Hallucinogens16.750.033.30.00.00.00.00.018.564
Volatile substances45.148.14.91.20.00.00.00.616.31629
Cannabis 35.043.411.75.22.41.30.60.318.11167129
Other substances 7.630.412.711.47.63.87.619.029.479126
Total14.642.822.99.74.42.31.42.021.25752717

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, HR, TR 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010